Technological Solutions for Diagnosis, Management and Treatment of Alzheimer's Disease-Related Symptoms: A Structured Review of the Recent Scientific Literature

被引:18
|
作者
Cammisuli, Davide Maria [1 ]
Cipriani, Gabriele [2 ]
Castelnuovo, Gianluca [1 ,3 ]
机构
[1] Catholic Univ, Dept Psychol, I-20123 Milan, Italy
[2] Versilia Hosp, Div Neurol, I-55049 Lido Di Camaiore, Italy
[3] Ist Auxol Italiano IRCCS, Clin Psychol Res Lab, I-28824 Verbania, Italy
关键词
Alzheimer's disease; mental health technology; digital devices; applications; sensors; virtual reality; empowerment; ASSOCIATION WORKGROUPS; NATIONAL INSTITUTE; RECOMMENDATIONS; IMPAIRMENT; GUIDELINES; PEOPLE; TASK;
D O I
10.3390/ijerph19053122
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
In people with Alzheimer's disease (PwAD), there is a need for specific tools for the timely diagnosis, management, and treatment of symptoms. New technological solutions, including digital devices, application programs (apps), sensors and virtual reality, represent promising possibilities for objective and reliable assessment, monitoring and intervention strategies in this field. Our structured review presents an up-to-date summary of the technological solutions for the (i) diagnosis, (ii) management and (iii) treatment of AD-related symptoms. To this end, we searched electronic databases (i.e., PubMed, Web of Science, and Cochrane Library) for studies published over the last 10 years. Two authors of the review extracted data of interest. A total of eight manuscripts were included. In the last decade, a series of technological solutions across AD stages have been proposed. These include: (i) innovative strategies for the early detection of deficits in finger dexterity, visuo-spatial abilities (including spatial navigation), divided attention and instrumental autonomy; (ii) tools to activate the patient's responsiveness in terms of alertness and mood improvement; and (iii) useful interventions for retrieving memories, increasing body movements and improving spatial cognition. Methodological limitations, mainly pertaining to the paucity of randomized controlled trials and comprehensive assessments, were observed. Advances in technology currently provide the potential for designing innovative methods for evaluating, controlling and handling AD-related symptoms. The co-creation of technological solutions with all stakeholders represents the best way to design effective strategies for PwAD.
引用
收藏
页数:10
相关论文
共 50 条
  • [11] IKKβ Deficiency in Myeloid Cells Ameliorates Alzheimer's Disease-Related Symptoms and Pathology
    Liu, Yang
    Liu, Xu
    Hao, Wenlin
    Decker, Yann
    Schomburg, Robert
    Fueloep, Livia
    Pasparakis, Manolis
    Menger, Michael D.
    Fassbender, Klaus
    JOURNAL OF NEUROSCIENCE, 2014, 34 (39) : 12982 - 12999
  • [12] Behavioural and psychological symptoms of dementia in mouse models of Alzheimer's disease-related pathology
    Kosel, Filip
    Pelley, Jessica M. S.
    Franklin, Tamara B.
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2020, 112 : 634 - 647
  • [13] Recent Advancements in the Early Diagnosis and Treatment of Alzheimer's Disease
    Wu, Ye
    Fu, Li
    Li, Qianqian
    Gao, Xiang
    Zhang, Yingjun
    Jin, Chuanfei
    Ding, Feiqing
    Hong, Sheng
    Cai, Hui
    Li, Yiliang
    ADVANCED THERAPEUTICS, 2023, 6 (11)
  • [14] Recent Trends in Nano-Particulate Carriers for the Diagnosis and Treatment of Alzheimer's Disease
    Mazahir, Farhan
    Yadav, Awesh K.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2023, 22 (04) : 477 - 499
  • [15] Recent Update on the Alzheimer's Disease Progression, Diagnosis and Treatment Approaches
    Malaiya, Akanksha
    Singhai, Mansha
    Singh, Manisha
    Prajapati, Shiv Kumar
    Choudhury, Hira
    Fatima, Mahak
    Alexander, Amit
    Dubey, Sunil Kumar
    Greish, Khaled
    Kesharwani, Prashant
    CURRENT DRUG TARGETS, 2022, 23 (10) : 978 - 1001
  • [16] Biofluid-based biomarkers for Alzheimer's disease-related pathologies: An update and synthesis of the literature
    Zetterberg, Henrik
    ALZHEIMERS & DEMENTIA, 2022, 18 (09) : 1687 - 1693
  • [17] Pimavanserin for the treatment of psychosis in Alzheimer's disease: A literature review
    Srinivasan, Shilpa
    Tampi, Rajesh R.
    Balaram, Kripa
    Kapoor, Arushi
    WORLD JOURNAL OF PSYCHIATRY, 2020, 10 (07): : 162 - 174
  • [18] Ethical issues in genomics research in persons with Alzheimer's Disease/Alzheimer's Disease-related dementia (AD/ADRD): a systematic review
    Yakubu, Aminu
    Adedeji, Isaac
    Maduka, Oluchi C.
    Jegede, Ayodele
    Adebamowo, Clement
    BMC MEDICAL ETHICS, 2024, 25 (01):
  • [19] Wavelet Energy and Wavelet Coherence as EEG Biomarkers for the Diagnosis of Parkinson's Disease-Related Dementia and Alzheimer's Disease
    Jeong, Dong-Hwa
    Kim, Young-Do
    Song, In-Uk
    Chung, Yong-An
    Jeong, Jaeseung
    ENTROPY, 2016, 18 (01):
  • [20] Review of triazole scaffolds for treatment and diagnosis of Alzheimer's disease
    Li, Qi
    Qi, Shulei
    Liang, Jinxin
    Tian, Yuqing
    Liao, Qinghong
    Xing, Shuaishuai
    Han, Lingfei
    Chen, Xuehong
    He, Siyu
    CHEMICO-BIOLOGICAL INTERACTIONS, 2023, 382